Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
30.46
-0.13 (-0.42%)
At close: Sep 17, 2025, 4:00 PM EDT
30.46
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:10 PM EDT
Azenta Market Cap
Azenta has a market cap or net worth of $1.40 billion as of September 17, 2025. Its market cap has decreased by -42.11% in one year.
Market Cap
1.40B
Enterprise Value
913.61M
1-Year Change
-42.11%
Ranking
Category
Stock Price
$30.46
Market Cap Chart
Since December 1, 1998, Azenta's market cap has increased from $156.00M to $1.40B, an increase of 795.05%. That is a compound annual growth rate of 8.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 1.40B | -49.01% |
Dec 31, 2024 | 2.75B | -38.94% |
Dec 29, 2023 | 4.50B | 3.18% |
Dec 30, 2022 | 4.37B | -43.01% |
Dec 31, 2021 | 7.66B | 53.08% |
Dec 31, 2020 | 5.00B | 65.34% |
Dec 31, 2019 | 3.03B | 63.89% |
Dec 31, 2018 | 1.85B | 11.18% |
Dec 29, 2017 | 1.66B | 41.81% |
Dec 30, 2016 | 1.17B | 62.52% |
Dec 31, 2015 | 720.70M | -15.39% |
Dec 31, 2014 | 851.80M | 22.12% |
Dec 31, 2013 | 697.50M | 30.67% |
Dec 31, 2012 | 533.80M | -21.43% |
Dec 30, 2011 | 679.40M | 15.25% |
Dec 31, 2010 | 589.50M | 6.85% |
Dec 31, 2009 | 551.70M | 49.51% |
Dec 31, 2008 | 369.00M | -63.14% |
Dec 31, 2007 | 1.00B | -7.76% |
Dec 29, 2006 | 1.09B | 91.38% |
Dec 30, 2005 | 567.10M | -26.06% |
Dec 31, 2004 | 767.00M | -13.40% |
Dec 31, 2003 | 885.70M | 112.40% |
Dec 31, 2002 | 417.00M | -48.51% |
Dec 31, 2001 | 809.90M | 67.58% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 686.51B |
Johnson & Johnson | 424.98B |
AbbVie | 382.04B |
UnitedHealth Group | 307.73B |
Novo Nordisk | 253.09B |
AstraZeneca | 240.11B |
Novartis AG | 237.94B |
Abbott Laboratories | 231.06B |